Tekmira Pharmaceuticals Corporation to Host Research and Development Webinar Providing Corporate Update on Product Pipeline
10/3/2013 10:02:43 AM
VANCOUVER, British Columbia, Oct. 3, 2013 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics announced that management will be hosting a web-based seminar (Webinar) to provide a corporate update on its pipeline of therapeutic candidates on Tuesday, October 8, 2013 at 4:00 pm ET / 1:00 pm PT.
Help employers find you! Check out all the jobs and post your resume.